The blood-brain barrier accessibility of a heparin-derived oligosaccharides C3. (Q48581408)

13 February 2018

title

The blood-brain barrier accessibility of a heparin-derived oligosaccharides C3. (English)

1 reference

13 February 2018

1 reference

1 reference

1

1 reference

13 February 2018

author name string

Bertalan Dudas

2

1 reference

13 February 2018

Matthew Hejna

3

1 reference

13 February 2018

Umberto Cornelli

4

1 reference

13 February 2018

John M Lee

5

1 reference

13 February 2018

Stanley Lorens

6

1 reference

13 February 2018

Ronald Mervis

7

1 reference

13 February 2018

Israel Hanin

8

1 reference

13 February 2018

Jawed Fareed

9

1 reference

13 February 2018

publication date

1 March 2002

1 reference

13 February 2018

published in

Thrombosis Research

1 reference

13 February 2018

volume

105

1 reference

13 February 2018

issue

5

1 reference

13 February 2018

page(s)

447-453

1 reference

13 February 2018

Treatment of Alzheimer's disease

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900050-6

7 January 2021

Novel m1 muscarinic agonists in treatment and delaying the progression of Alzheimer's disease: an unifying hypothesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900050-6

7 January 2021

Orally active NGF synthesis stimulators: potential therapeutic agents in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900050-6

7 January 2021

Role of estrogen replacement therapy in memory enhancement and the prevention of neuronal loss associated with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900050-6

7 January 2021

Multiple antioxidants in the prevention and treatment of neurodegenerative disease: analysis of biologic rationale

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900050-6

7 January 2021

Alzheimer's disease and inflammation: a review of cellular and therapeutic mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900050-6

7 January 2021

Aggregation State and Neurotoxic Properties of Alzheimer Beta-Amyloid Peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900050-6

7 January 2021

Arresting amyloidosis in vivo using small-molecule anionic sulphonates or sulphates: implications for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900050-6

7 January 2021

Heparin Oligosaccharides that Pass the Blood‐Brain Barrier Inhibit β‐Amyloid Precursor Protein Secretion and Heparin Binding to β‐Amyloid Peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900050-6

7 January 2021

Aggregation of secreted amyloid beta-protein into sodium dodecyl sulfate-stable oligomers in cell culture

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900050-6

7 January 2021

Differential binding of vascular cell-derived proteoglycans (perlecan, biglycan, decorin, and versican) to the beta-amyloid protein of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900050-6

7 January 2021

Proteoglycans and the acute-phase response in Alzheimer's disease brain

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900050-6

7 January 2021

Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900050-6

7 January 2021

Sulfated glycosaminoglycans and dyes attenuate the neurotoxic effects of beta-amyloid in rat PC12 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900050-6

7 January 2021

Glycosaminoglycan polysulfate (Ateroid) in old-age dementias: effects upon depressive symptomatology in geriatric patients

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900050-6

7 January 2021

10.1016/S0049-3848(02)00050-6

Identifiers

DOI

1 reference

13 February 2018

1 reference

13 February 2018